SUMMARY A 24 year old woman with Crohn's disease presented initially with a severe primary genital herpes infection. After the first attack frequent recurrences occurred on the hands, feet, and genitalia. The patient was treated with oral acyclovir for 12 weeks, during which time she had two brief minor recurrences. After treatment was stopped lesions recurred at the same sites.
Introduction
Genital herpes is a distressing, painful, and recurrent condition for which there was no effective treatment until recently. We describe a patient with genital herpes whose lesions disseminated to other cutaneous areas and whose disease was controlled by continuous oral acyclovir.
Case report
A 24 year old woman journalist was admitted to the Leeds Infirmary with a severe attack of primary genital herpes in mid May 1982. She also had longstanding Crohn's disease for which she had been taking azothiaprine 100 mg daily and prednisolone 7.5 mg daily for 10 years. Her attack of herpes was first treated with topical idoxuridine for one week, with no effect, and she was therefore given a five day course of intravenous acyclovir 250 mg eight hourly. By was isolated from the finger, heel, and toe. The patient was advised to bathe the affected areas with saline, and all the lesions were healing when she was seen a week later.
In early July she enjoyed a week free of any lesions, but on 15 July vesicles appeared on the vulva and right toe and when she was examined on 22 July the cervix was also affected. The lesions had healed without treatment by the end of July, but there was a further recurrence a week later on the finger, heel, toe, vulva, and cervix. The patient was then given a twelve week course of oral acyclovir 200 mg four times daily, and all lesions disappeared within five days. Two minor recurrences occurred during the treatment period (early September to mid October), one on the finger and one on the vulva; both lasted less than 12 hours, consisted of a single vesicle, and occurred 10-12 hours after the patient had missed a tablet. A week after treatment was stopped lesions recurred on the heel and toe, and within a few days the vulva, cervix, and finger were also affected. 
